PEAβ Triggers Cognitive Decline and Amyloid Burden in a Novel Mouse Model of Alzheimer’s Disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: 10.3390/ijms22137062
- Event
-
Veröffentlichung
- (where)
-
Aachen
- (who)
-
Universitätsbibliothek der RWTH Aachen
- (when)
-
2021
- Creator
-
Camargo, Luana Cristina
Schöneck, Michael
Sangarapillai, Nivethini
Honold, Dominik
Shah, N. Jon
Langen, Karl-Josef
Willbold, Dieter
Kutzsche, Janine
Schemmert, Sarah
Willuweit, Antje
- DOI
-
10.18154/RWTH-CONV-248382
- URN
-
urn:nbn:de:101:1-2023020301203838827393
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Camargo, Luana Cristina
- Schöneck, Michael
- Sangarapillai, Nivethini
- Honold, Dominik
- Shah, N. Jon
- Langen, Karl-Josef
- Willbold, Dieter
- Kutzsche, Janine
- Schemmert, Sarah
- Willuweit, Antje
- Universitätsbibliothek der RWTH Aachen
Time of origin
- 2021
Other Objects (12)
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Pharmakokinetische Charakterisierung D-enantiomerer Peptide zur Therapie der Alzheimer'schen Demenz
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes
Pharmakokinetische Charakterisierung D-enantiomerer Peptide zur Therapie der Alzheimer'schen Demenz
Preclinical pharmacokinetics and cerebral distribution of D-enantiomeric peptides for the treatment of Alzheimer’s disease
Die Struktur des Transaktivator-Proteins aus dem Pferdeanämie-Virus in Lösung
Pharmacokinetic properties of D-peptides designed for treatment of Alzheimer’s disease
Structural analysis and aggregation of Alzheimer’s disease related pyroglutamate-modified amyloid-β
Advancement of the detection of individual Alzheimer’s amyloid-β oligomers in biological samples
Selection and characterization of Amyloid-β1-42 binding D-enantiomeric peptides for potential therapeutic intervention of Alzheimer´s disease
Einfluss von Thrombozyten auf die Progression der Alzheimer Erkrankung
Aβ Oligomer Elimination Restores Cognition in Transgenic Alzheimer’s Mice with Full-blown Pathology
Selektion und Charakterisierung spezifischer Bindeproteine für amyloidogene Proteine der Alzheimer-Krankheit
Evaluation von D-enantiomeren Peptiden als mögliche Wirkstoffkandidaten in einem Alzheimer-Mausmodell
Interaction of amyloid peptides with biomembranes and its implications in Alzheimers disease and type II diabetes